Federated Hermes’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.72K | Hold |
6,541
| – | – | ﹤0.01% | 1939 |
|
|
2025
Q1 | $4.08K | Buy |
6,541
+2,058
| +46% | +$1.28K | ﹤0.01% | 1899 |
|
|
2024
Q4 | $7.49K | Buy |
+4,483
| New | +$7.49K | ﹤0.01% | 1864 |
|
|
2024
Q3 | – | Sell |
-2,329
| Closed | -$14K | – | 2059 |
|
|
2024
Q2 | $14K | Sell |
2,329
-199,033
| -99% | -$1.2M | ﹤0.01% | 1753 |
|
|
2024
Q1 | $2.25M | Buy |
201,362
+4,826
| +2% | +$53.8K | 0.01% | 910 |
|
|
2023
Q4 | $2.93M | Sell |
196,536
-54,824
| -22% | -$816K | 0.01% | 851 |
|
|
2023
Q3 | $1.21M | Sell |
251,360
-3,610
| -1% | -$17.3K | ﹤0.01% | 1052 |
|
|
2023
Q2 | $1.91M | Sell |
254,970
-255,696
| -50% | -$1.92M | ﹤0.01% | 963 |
|
|
2023
Q1 | $2.31M | Buy |
510,666
+46,637
| +10% | +$211K | 0.01% | 912 |
|
|
2022
Q4 | $5.23M | Sell |
464,029
-685
| -0.1% | -$7.72K | 0.01% | 678 |
|
|
2022
Q3 | $4.45M | Buy |
464,714
+7,961
| +2% | +$76.2K | 0.01% | 696 |
|
|
2022
Q2 | $3.7M | Buy |
456,753
+402,646
| +744% | +$3.26M | 0.01% | 764 |
|
|
2022
Q1 | $914K | Buy |
+54,107
| New | +$914K | ﹤0.01% | 1277 |
|
|
2020
Q4 | – | Sell |
-5,000
| Closed | -$188K | – | 2233 |
|
|
2020
Q3 | $188K | Buy |
+5,000
| New | +$188K | ﹤0.01% | 1660 |
|